Author Correction
Volume 52, no. 12, p. 4435–4436, 2014. Page 4436, Acknowledgment section, line 2: “Merck Canada Inc.” should read “Pfizer Canada Inc.”
. 2015 Jan 23;53(2):756. doi: 10.1128/JCM.03369-14
Correction for Dufresne et al., Instability of Aspergillus Galactomannan in Stored Clinical Samples
Simon F Dufresne
1, Stéphanie Beauchemin
1, Christian Lavallée
1, Michel Laverdière
1
Simon F Dufresne
1Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
Find articles by Simon F Dufresne
Stéphanie Beauchemin
1Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
Find articles by Stéphanie Beauchemin
Christian Lavallée
1Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
Find articles by Christian Lavallée
Michel Laverdière
1Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
Find articles by Michel Laverdière
1Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
Citation Dufresne SF, Beauchemin S, Lavallée C, Laverdière M. 2015. Correction for Dufresne et al., Instability of Aspergillus galactomannan in stored clinical samples. J Clin Microbiol 53:756. doi:10.1128/JCM.03369-14.
Issue date 2015 Feb.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
PMCID: PMC4298523 PMID: 25617445
This corrects the article "Instability of Aspergillus Galactomannan in Stored Clinical Samples" in volume 52 on page 4435.